Journals / Solunum Hastalıkları / 2006 / Cilt: 17 - Sayı: 3

Hepatitis C virus and the lung

Hepatit C virüsü ve akciğerler

Pages
149–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These include primary effects on lung functions; secondary effects in settings of progressive liver disease and drug treatment for HCV.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatitis C virus (HCV) infection is an important public health problem worldwide.
📊
Key Findings & Data:It is estimated that 3% of the world population is chronically infected with HCV.
💡
Conclusion & Impact:These include primary effects on lung functions; secondary effects in settings of progressive liver disease and drug treatment for HCV.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit C · kronik · Hepacivirus

Abstract

Hepatitis C virus (HCV) infection is an important public health problem worldwide. It is estimated that 3% of the world population is chronically infected with HCV. Chronic HCV infection has been reported in association with several extrahepatic manifestations including recently recognized effects on the lung. These include primary effects on lung functions; secondary effects in settings of progressive liver disease and drug treatment for HCV.

Özet

Hepatit C virüsü (HCV) infeksiyonu dünyada önemli bir halk sağlığı problemidir. Yaklaşık dünya nüfusunun %3'ü HCV ile kronik olarak infektedir. Kronik HCV infeksiyonu son zamanlarda akciğerleri de içine alan birçok ekstrahepatik tutulumla birlikte anılmaktadır. Bunlar primer olarak akciğer fonksiyonlarına etki, progresif karaciğer hastalığı ve HCV'nin ilaç tedavisinin akciğere sekonder etkilerini içerir.

🔖

Cite This Article

ERTÜRK, A. (2006). Hepatitis C virus and the lung. Solunum Hastalıkları, Cilt: 17 - Sayı: 3, 149–152. https://ajindex.com/articles/318486

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. John Cohen. The scientific challence of hepatitis C. Science 1999;285:26-31
  2. Uzun Ö. Güncel Bilgiler Işığında İnfeksiyon Hastalıkları. Ankara: Bilimsel Tıp Yayınevi, 2002;564
  3. Marcellin P. Hepatitis C: The clinical spectrum of the disease. J Hepatol 1999;31(Suppl 1):9-16
  4. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-100
  5. Erkek E, Bozdoğan O, Olut AI. Hepatitis C virus infection prevalence in lichen planus: Examination of lesional and normal skin of hepatitis C virus-infected patients with licen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 2001;26:540-4
  6. Lovy MR, Starkebaum G. Rheumatic disorders associated with hepatitis C. Baillieres. Best Pract Res Clin Rheumatol 2000;14:535-57
  7. Agnello V, De Rosa FG. Extrahepatic disease manifestations of HCV infection: Some current issues. J Hepatol 2004;40:341-52
  8. Moorman J, Saad M, Kosseifi S, Krishnaswamy G. Hepatitis C virus and the lung: Implications for therapy. Chest 2005;128:2882-92
  9. Ueda T, Ohta K, Suzuki N, et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992;146:266-8
  10. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993;148:1683-4
  11. Meliconi R, Andreone P, Fasano L, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996;51:315-7
  12. Ferri C, La Civita L, Fazzi P, et al. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997;36:360-5
  13. Kubo K, Yamaguchi S, Fujimoto K, et al. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax 1996;51:312-4
  14. Yamaguchi S, Kubo K, Fujimoto K, et al. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax 1997;52:33-7
  15. Manganelli P, Salaffi F, Subiaco S, et al. Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. Br J Rheumatol 1996;35:978-82
  16. Salaffi F, Manganelli P, Carotti M, et al. Mixed cryoglobulinemia: Effect of alpha-interferon on subclinical lymphocyte alveolitis. Clin Exp Rheumatol 1996;14: 219-1718
  17. Idilman R, Cetinkaya H, Savas I, et al. Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C J Med Virol 2002;66:34-9
  18. Okutan O,